OBJECTIVE: Investigation of the effect of hypertension on endothelium-dependent relaxation and release of nitric oxide (NO) in normotensive and renal hypertensive rats. DESIGN AND METHODS: Sprague-Dawley rats were randomly allocated into two groups: uninephrectomized controls and one-kidney one-clip (Goldblatt hypertension) hypertensive rats, a non-renin dependent model of hypertension. After 10 weeks and in the presence of the cyclooxygenase inhibitor indomethacin, simultaneous measurements of the NO concentration, measured with a NO-specific microelectrode and endothelium-dependent relaxation were performed in isolated rat superior mesenteric arteries. RESULTS: Addition of the NO scavenger, oxyhaemoglobin, showed that basal NO concentration was unaltered in arterial segments from hypertensive rats. In norepinephrine-contracted arteries, acetylcholine increased the NO concentration and caused relaxations, and both parameters were significantly reduced in renal hypertensive arteries. Relaxations induced by the NO donor, S-nitroso-N-acetylpenicillamine were reduced. The superoxide scavenger, superoxide dismutase, and the NO synthase substrate, l-arginine, did not change the increase in NO concentration or acetylcholine relaxation in arteries from normotensive or renal hypertensive animals. In contrast, the NO synthase inhibitor, asymmetric dimethyl l-arginine, reduced the NO concentration and acetylcholine relaxation, while these responses were abolished in the presence of oxyhaemoglobin. CONCLUSIONS: This study provides direct evidence that reduced endothelium-dependent relaxations in the superior mesenteric artery from renal hypertensive rats is due, at least in part, to diminished NO release. The reduced NO release and relaxation persist in the presence of excess of substrate for NO synthase.
OBJECTIVE: Investigation of the effect of hypertension on endothelium-dependent relaxation and release of nitric oxide (NO) in normotensive and renal hypertensiverats. DESIGN AND METHODS: Sprague-Dawley rats were randomly allocated into two groups: uninephrectomized controls and one-kidney one-clip (Goldblatt hypertension) hypertensiverats, a non-renin dependent model of hypertension. After 10 weeks and in the presence of the cyclooxygenase inhibitor indomethacin, simultaneous measurements of the NO concentration, measured with a NO-specific microelectrode and endothelium-dependent relaxation were performed in isolated rat superior mesenteric arteries. RESULTS: Addition of the NO scavenger, oxyhaemoglobin, showed that basal NO concentration was unaltered in arterial segments from hypertensiverats. In norepinephrine-contracted arteries, acetylcholine increased the NO concentration and caused relaxations, and both parameters were significantly reduced in renal hypertensive arteries. Relaxations induced by the NO donor, S-nitroso-N-acetylpenicillamine were reduced. The superoxide scavenger, superoxide dismutase, and the NO synthase substrate, l-arginine, did not change the increase in NO concentration or acetylcholine relaxation in arteries from normotensive or renal hypertensive animals. In contrast, the NO synthase inhibitor, asymmetric dimethyl l-arginine, reduced the NO concentration and acetylcholine relaxation, while these responses were abolished in the presence of oxyhaemoglobin. CONCLUSIONS: This study provides direct evidence that reduced endothelium-dependent relaxations in the superior mesenteric artery from renal hypertensiverats is due, at least in part, to diminished NO release. The reduced NO release and relaxation persist in the presence of excess of substrate for NO synthase.
Authors: Xiao Yu Tian; Wing Tak Wong; Fung Ping Leung; Yang Zhang; Yi-Xiang Wang; Hung Kay Lee; Chi Fai Ng; Zhen Yu Chen; Xiaoqiang Yao; Chak Leung Au; Chi Wai Lau; Paul M Vanhoutte; John P Cooke; Yu Huang Journal: Antioxid Redox Signal Date: 2011-12-02 Impact factor: 8.401
Authors: Norma B Ojeda; Suttira Intapad; Thomas P Royals; Joshua T Black; John Henry Dasinger; F Lee Tull; Barbara T Alexander Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-08-10 Impact factor: 3.619
Authors: Ahmad F Ahmeda; Mark G Rae; Mohammed F Al Otaibi; Lamyia M Anweigi; Edward J Johns Journal: J Physiol Biochem Date: 2016-12-09 Impact factor: 4.158
Authors: Caroline Bleakley; Paul Kevin Hamilton; Richard Pumb; Mark Harbinson; Gary Eugene McVeigh Journal: J Clin Hypertens (Greenwich) Date: 2015-04-10 Impact factor: 3.738
Authors: E Stankevicius; V Lopez-Valverde; L Rivera; A D Hughes; M J Mulvany; Ulf Simonsen Journal: Br J Pharmacol Date: 2006-09-11 Impact factor: 8.739